(lp0
S'Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed ... Yahoo Finance - Mar 17, 2017 PALATINE, Ill., March 17, 2017  -- Acura Pharmaceuticals, Inc.  and MainPointe Pharmaceuticals, LLC today announced that they have entered into a License Agreement  to have MainPointe exclusively market&nbsp;...ACURA PHARMACEUTICALS, INC.  Files An 8-K Entry into a Material ... - Market Exclusive'
p1
aS'Acura Pharmaceuticals Seeks To Raise $5 Million In Offering Seeking Alpha - Feb 7, 2017 Acura Pharmaceuticals has filed to raise $5 million in a follow-on stock and warrant offering. The company is commercializing tamper-resistant medication technologies, but appears to be running out of money and time.'
p2
aS"Delisting of Securities of Spanish Broadcasting System, Inc., Acura ... Nasdaq - Mar 13, 2017 NEW YORK, March 13, 2017  -- The Nasdaq Stock Market announced today that it will delist the common stock Class A of Spanish Broadcasting System, Inc. Spanish Broadcasting System, Inc.'s stock was suspended on January 19,&nbsp;..."
p3
aS"Acura Pharmaceuticals Inc. ACUR  Wall Street Journal - Feb 13, 2011 News Acura Pharmaceuticals Inc.ACUR. No news for ACUR in the past two years. Key Stock Data ? P/E Ratio : The Price to Earnings  ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the&nbsp;..."
p4
aS'Acura Pharmaceuticals Inc : Is An Exposure Worth The Risk? Insider Financial - Feb 9, 2017 Acura Pharmaceuticals, Inc. started out this week at circa $0.5 a share. By mid week, it had risen to more than $1.3, and currently trades for just shy of $1.Is Acura Pharmaceuticals, Inc.  in Oversold Territory? - The Oracle ExaminerStocks in the Spotlight: Acura Pharmaceuticals, Inc.  , Ironwood ... - NYSE Journal '
p5
aS'Acura Pharmaceuticals, Inc.  To Delist From NASDAQ; Shares Fall 23% Smarter Analyst - Feb 15, 2017 Acura Pharmaceuticals, Inc.  investors are running for the hills, after the drug announced that its shares will be delisted from the NASDAQ Stock Market.Acura Pharmaceuticals Common Stock To Trade On The OTCQB Market - GlobeNewswire '
p6
aS'Stock Update : Acura Pharmaceuticals, Inc. Provides Development ... Smarter Analyst - Dec 14, 2016 Acura Pharmaceuticals, Inc.  announced that the U.S. Food and Drug Administration  has provided the Company with advice on the continued development of its product candidate LTX-04  which utilizes the&nbsp;...'
p7
aS'Broker Rating Update on Vivint Solar, Inc.  Acura Pharmaceuticals ... Rives Journal - Mar 17, 2017 Stock research firms currently have a positive stance on shares of Vivint Solar, Inc. . Analysts are projecting that the stock will reach $5.66 on a short term  basis.'
p8
aS"Acura Pharmaceuticals'  CEO Bob Jones on Q3 2016 Results - Earnings Call ... Seeking Alpha - Nov 15, 2016 ... to maximize this potential, future product sales, financial results and the company's strategy for near-term financing and long-term growth."
p9
aS'ACURA PHARMACEUTICALS, INC.  Files An 8-K Departure of Directors ... Market Exclusive - Feb 25, 2017 On February 24, 2017, we increased the maximum bonus payable to Albert W. Brzeczko, Vice President Technical Affairs of our subsidiary Acura Pharmaceutical Technologies, Inc. from 35% to 50% of base salary under our non-equity bonus incentive plan.'
p10
a.